Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
TCBP Announces Preliminary Agreement for Acquisition of NK Platform Technologies
Friday, April 05, 2024TC BioPharm a biotechnology company in the clinical stage focusing on the development of allogeneic gammadelta T cell therapies for cancer and other ailments
SpliSense Granted FDA Clearance for Investigational New Drug Application to Initiate Phase 2 Trials of SPL84 in Cystic Fibrosis Treatment
Thursday, April 04, 2024SpliSense a biotechnology company specializing in RNAbased therapies for pulmonary diseases has received clearance from the US Food and Drug Administration for its Investigational New Drug
Prozomix and Ginkgo Bioworks Partner on Advancing Sustainable API Manufacturing Through Next-Gen Enzyme Development
Thursday, April 04, 2024Prozomix a UKbased biotech company specializing in innovative biocatalyst discovery and manufacturing has formed a new partnership with Ginkgo Bioworks a company focused on cell programming
Partner Therapeutics’ Leukine® (sargramostim) Granted Approval in Japan for Treating Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Thursday, April 04, 2024Partner Therapeutics Inc has recently announced that Nobelpharma its partner has received approval from the Japanese Pharmaceuticals and Medical Device Agency for the inhaled use of Leukine
Jazz Pharmaceuticals Completes Biologics License Application for Zanidatamab Targeting Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
Wednesday, April 03, 2024Jazz Pharmaceuticals plc has announced the completion of the rolling submission of a Biologics License Application to the US Food and Drug Administration for accelerated approval of zanidatamab
Ginkgo Bioworks Strengthens Next-Gen CAR Designs Through Acquisition of Modulus Therapeutics' Cell Therapy Assets
Wednesday, April 03, 2024Ginkgo Bioworks made an announcement today regarding the acquisition of Modulus Therapeutics cell therapy platform assets which include their chimeric antigen receptor and switch receptor libraries
Initial Dosing of Patient Commences in Clinical Study Investigating YOLT-101 for FH Therapy
Wednesday, April 03, 2024YolTech Therapeutics has announced a significant milestone in its development of YOLT an in vivo genome editing candidate for treating Familial Hypercholesterolemia The company has initiated
Datopotamab Deruxtecan Biologics License Application Accepted for Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer in the U.S.
Tuesday, April 02, 2024Daiichi Sankyo and AstraZeneca have jointly submitted a Biologics License Application for datopotamab deruxtecan to the US regulatory authorities This submission aims to seek approval for the treatment
Eisai Submits Supplemental Biologics License Application to FDA for IV Maintenance Dosing of LEQEMBI® in Early Alzheimer's Treatment
Monday, April 01, 2024Eisai Co Ltd and Biogen Inc have jointly announced the submission of a Supplemental Biologics License Application to the US Food and Drug Administration for monthly intravenous
Bridge Biotherapeutics Partners with Emory University School of Medicine to Investigate Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade
Saturday, March 30, 2024Bridge Biotherapeutics a South Korean biotech firm specializing in cancer fibrosis and inflammation
